IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Darwin Global Management, Ltd.

Q4 2025 Holdings

Filed 2026-02-17 | 6 holdings | $4.9B | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Insmed Inc(INSM)COM PAR $.01457669307$3.6B20,933,27773.8%
Belite BIO Inc(BLTE)SPONSORED ADS07782B104$486.9M3,027,7049.9%
Abivax SA(ABVX)SPONSORED ADS00370M103$439.7M3,178,5018.9%
Cidara Therapeutics Inc(CDTX)COM NEW171757206$220.2M997,1964.5%
Wave Life Sciences LTD(WVE)SHSY95308105$125.2M7,298,4212.5%
Capricor Therapeutics Inc(CAPR)COM NEW14070B309$23.2M800,0000.5%